AB
VBIV

Amalgamated Bank’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Amalgamated Bank’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-659
Closed -$6K – 3152
2023
Q1 		$6K Sell
659
-149
-18% -$2.11K ﹤0.01% 2887
2022
Q4 		$9K Hold
808
– – ﹤0.01% 2892
2022
Q3 		$17K Hold
808
– – ﹤0.01% 2863
2022
Q2 		$20K Sell
808
-187
-19% -$6.36K ﹤0.01% 2861
2022
Q1 		$50K Sell
995
-76
-7% -$3.75K ﹤0.01% 2489
2021
Q4 		$75K Sell
1,071
-7
-0.6% -$590 ﹤0.01% 2088
2021
Q3 		$101K Sell
1,078
-59
-5% -$5.61K ﹤0.01% 2081
2021
Q2 		$114K Buy
1,137
+290
+34% +$28.3K ﹤0.01% 2107
2021
Q1 		$79K Hold
847
– – ﹤0.01% 1562
2020
Q4 		$70K Buy
847
+38
+5% +$3.24K ﹤0.01% 1546
2020
Q3 		$69K Sell
809
-18
-2% -$2.1K ﹤0.01% 1436
2020
Q2 		$77K Buy
827
+101
+14% +$5.56K ﹤0.01% 1425
2020
Q1 		$21K Buy
726
+213
+42% +$8.28K ﹤0.01% 1621
2019
Q4 		$21K Buy
513
+32
+7% +$701 ﹤0.01% 1830
2019
Q3 		$7K Sell
481
-3
-0.6% -$63 ﹤0.01% 1770
2019
Q2 		$17K Buy
+484
New +$26.2K ﹤0.01% 1792

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amalgamated Bank's VBIV Position: Q2 2023 in Review

Amalgamated Bank sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 659 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in VBIV in Q2 2019 and held it in 16 quarters. The position peaked at $114K in Q2 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

  • Amalgamated Bank reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
  • Amalgamated Bank sold 659 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $6K.
  • Amalgamated Bank first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2019 and held it in 16 quarters.
  • Amalgamated Bank's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $114K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Amalgamated Bank's 13F filing for Q2 2023, filed 11 Aug 2023.